Challenges in the Diagnosis of NTRK Fusion-Positive Cancers
J Thorac Oncol
.
2020 Jul;15(7):e108-e110.
doi: 10.1016/j.jtho.2019.05.001.
Authors
Oliver Gautschi
1
,
Lukas Bubendorf
2
,
Serge Leyvraz
3
,
Roopika Menon
4
,
Joachim Diebold
5
Affiliations
1
Cantonal Hospital Lucerne, Lucerne, Switzerland. Electronic address: oliver.gautschi@luks.ch.
2
University Hospital Basel, Basel, Switzerland.
3
Charité Comprehensive Cancer Center, Berlin, Germany.
4
NEO New Oncology GmbH, Cologne, Germany.
5
Cantonal Hospital Lucerne, Lucerne, Switzerland.
PMID:
32593446
DOI:
10.1016/j.jtho.2019.05.001
No abstract available
Publication types
Letter
Comment
MeSH terms
Biomarkers
Carcinoma, Non-Small-Cell Lung*
Humans
Lung Neoplasms*
Neoplasms* / diagnosis
Neoplasms* / genetics
Receptor, trkA
Substances
Biomarkers
Receptor, trkA